Peter Revill retweeted
It’s #WorldHepatitisDay. A person dying every 30 seconds from a hepatitis-related illness is an ongoing emergency. It’s vital we accelerate the fight against viral hepatitis, just as Prof. Sharon Lewin—head of Melbourne’s @TheDohertyInst— is doing.
Peter Revill retweeted
At the White House with our #WorldHepatitisDay messages:
What are you waiting for?
300M reasons to end #HepB
We are fighting for our lives
We need access to treatment now!
Tick Tock, Time is up
Simplify #HepB Guidelines
The longer you wait, the earlier our fate!
#NotWaiting – at Washington, DC
Congratulations to Dr Loey Lung-Yi Mak from Hong Kong on receiving the EASL 2023 Emerging Leader award at the Liver Congress here in Vienna. A fantastic achievement from an inspiring clinician scientist and hepatitis virus researcher!!
106
Peter Revill retweeted
Hepatitis Australia welcomes @hepbvoices_au - the first hepatitis B community-led organization that is wholly led by people affected by hepatitis B in Australia.
We can’t wait to work together to get action and investment on Hepatitis B!
hepbvoices.au/
Peter Revill retweeted
Congratulations to @TheRMH and @TheDohertyInst's Prof @PeterRevill1, who today received more than $1.4M from @nhmrc. The funds will go toward his research into novel therapeutics for Hepatitis B. Read more about Peter's work on @TheDohertyInst website: doherty.edu.au/people/profes…
Delighted to have received an NHMRC ideas grant to pursue our HBV curative research. An amazing team effort building on years of collaborative research and I can’t wait to get cracking on this project!!
Peter Revill retweeted
Most people with #hepatitisB don’t look sick, so how do you fight an invisible disease?
You fund programs like screening, linkage to care, and advocacy, that shed light on this life-threatening disease that affects millions of people.
Donate today:
ow.ly/rL7I50LPmns
Peter Revill retweeted
Awesome post-doc job opp with Prof Jose Villadangos @TheDohertyInst @UniMelbMDHS Check it out.....Research Officer/Senior Research Officer in Immunology/Biochemistry/Cell Biology jobs.unimelb.edu.au/en/job/9…
Peter Revill retweeted
World first study of #hepatitisB virus using deep sequencing shows less diverse #HBV genomes more likely to respond to treatment, increasing likelihood of patients achieving functional cure. doherty.edu.au/news-events/n…
@PeterRevill1 @TheRMH @UniMelbMDHS
Peter Revill retweeted
Thrilled to see the Cumming Global Centre for Pandemic Therapeutics featured in @theage 52 News Makers for 2022! theage.com.au/interactive/20…
@UniMelb @UniMelbMDHS @TheRMH @ProfSharonLewin
Peter Revill retweeted
Congratulations to our Scientific Advisory Board member, Nobel Laureate Prof Françoise Barré-Sinoussi for being conferred with an honorary doctorate by @UniMelb, recognised for her lifetime contributions to #HIVcure and AIDS research go.unimelb.edu.au/u9te
@UniMelbMDHS @TheRMH
Peter Revill retweeted
Collaborative team from @TheDohertyInst @TheRMH @MIPS_Australia @PeterMacCC has received $1.7m in @dfjp funding over 5 years to advance world-first research into a cure for #hepatitis B virus infection.
doherty.edu.au/news-events/n…
@ColinPouton @pauellen #hepB
Peter Revill retweeted
Great work from @Chuan_Lim_VPRL and @BeardLabUofA + others. Human Liver Organoids as a Patient-derived Model for HBV Infection and Cellular Response. @UofA_SET @AusHepVirol @UniofAdelaide biorxiv.org/content/10.1101/…
Peter Revill retweeted
“Love your parents. We are so busy growing up, we often forget they are also growing old.”
Delighted our Hepatitis B Virus serum biomarkers review is featured on the cover of the November issue of Nature Reviews Gastroenterology and Hepatology- a truly global collaborative effort led by ICE-HBV nature.com/nrgastro/ @ICE_HBV @TheDohertyInst
Peter Revill retweeted
Excited to finally tweet about the launch of Computational Sciences Initiative at @TheDohertyInst , supported by J & M Wright Foundation. CSI focuses on computational approaches in 3 aspects of infectious disease: Discovery Research, Public Health, and Clinical and Health Systems
Peter Revill retweeted
Congrats Prof Laura Mackay for this brilliant achievement!
Laura Mackay is an internationally recognised expert in T cell immunity. Her landmark research papers have defined how memory T cell responses are generated in body tissues, and their role in viral and tumour immunity. @LMackayLab @TheDohertyInst @UniMelb #AAHMSFellows
Peter Revill retweeted
Great to see this ⬇️as #HBV has lived in hepatitis C's shadow for too long.
More education = better advocacy = more positive change!
@HepBFoundation @ICE_HBV @thatliverguy @OzCapucine @NO_hep
📢 #HBV #Cure FAQ series 💻 provide answers to key #research questions on #hepatitisB cure💪
❓Why do we need a Hepatitis B cure?
❓Clinical Trials: Why do we need them?
❓How possible is a cure for Hepatitis B?
Watch the series now!
➡️ https://nitter.gq/t.co/rzRJuEuM4k
@ICE_HBV
Peter Revill retweeted
"This is a significant day for research, for health, community and economic improvement." @DanielAndrewsMP @VicGovAu
Peter Revill retweeted
"We deeply thank Mr Geoff Cumming and his family for this transformational gift of $250m to establish a global centre for pandemic therapeutic research here in Melbourne and also acknowledges the significant contribution from the @VicGovAu." @ProfSharonLewin
